These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11114488)

  • 1. Treatment of depression and concomitant anxiety.
    Nutt D
    Eur Neuropsychopharmacol; 2000 Dec; 10 Suppl 4():S433-7. PubMed ID: 11114488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Montgomery SA; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly.
    van Dijk KN; de Vries CS; ter Huurne K; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    J Clin Epidemiol; 2002 Oct; 55(10):1049-53. PubMed ID: 12464383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The place for the tricyclic antidepressants in the treatment of depression.
    Boyce P; Judd F
    Aust N Z J Psychiatry; 1999 Jun; 33(3):323-7. PubMed ID: 10442787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing depression and anxiety in the elderly patient.
    Katona C
    Eur Neuropsychopharmacol; 2000 Dec; 10 Suppl 4():S427-32. PubMed ID: 11114487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.
    Lawrenson RA; Tyrer F; Newson RB; Farmer RD
    J Affect Disord; 2000 Aug; 59(2):149-57. PubMed ID: 10837883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of current treatment in panic disorder.
    den Boer JA; Slaap BR
    Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S25-30. PubMed ID: 9690962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.